{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:32:20Z","timestamp":1786984340481,"version":"build-2736575974"},"reference-count":32,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Auris Nasus Larynx"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.anl.2016.10.005","type":"journal-article","created":{"date-parts":[[2016,11,8]],"date-time":"2016-11-08T09:15:44Z","timestamp":1478596544000},"page":"404-410","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Clinical predictors of aminoglycoside-induced ototoxicity in drug-resistant Tuberculosis patients on intensive therapy"],"prefix":"10.1016","volume":"44","author":[{"given":"Olusola Ayodele","family":"Sogebi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bolanle Olufunlola","family":"Adefuye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen Oluwatosin","family":"Adebola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan Modupe","family":"Oladeji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taiwo Olugbemiga","family":"Adedeji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.anl.2016.10.005_bib0165","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.heares.2011.05.008","article-title":"New developments in aminoglycoside therapy and ototoxicity","volume":"281","author":"Xie","year":"2011","journal-title":"Hear Res"},{"key":"10.1016\/j.anl.2016.10.005_bib0170","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1039\/C5MD00453E","article-title":"A review of patents (2011\u20132015) towards combating resistance to and toxicity of aminoglycosides","volume":"7","author":"Chandrika","year":"2016","journal-title":"MedChemComm"},{"key":"10.1016\/j.anl.2016.10.005_bib0175","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1136\/thoraxjnl-2015-207245","article-title":"A systematic review and meta-analysis of the efficacy and safety of N-acetylcysteine in preventing aminoglycoside-induced ototoxicity: implications for the treatment of multidrug-resistant TB","volume":"70","author":"Kranzer","year":"2015","journal-title":"Thorax"},{"key":"10.1016\/j.anl.2016.10.005_bib0180","doi-asserted-by":"crossref","first-page":"886","DOI":"10.4314\/ahs.v13i4.4","article-title":"Clinical and audiometric features of presbycusis in Nigerians","volume":"13","author":"Sogebi","year":"2013","journal-title":"Afr Health Sci"},{"key":"10.1016\/j.anl.2016.10.005_bib0185","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1177\/0194599814565594","article-title":"Attenuation of streptomycin ototoxicity by tetramethylpyrazine in guinea pig cochlea","volume":"152","author":"Cui","year":"2015","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.anl.2016.10.005_bib0190","first-page":"14","article-title":"Does vitamin E prevent gentamicin-induced ototoxicity?","volume":"146","author":"Kharkheli","year":"2007","journal-title":"Georgian Med News"},{"key":"10.1016\/j.anl.2016.10.005_bib0195","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0076-6879(10)78021-6","article-title":"Aminoglycosides redesign strategies for improved antibiotics and compounds for treatment of human genetic diseases","volume":"478","author":"Pokrovskaya","year":"2010","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.anl.2016.10.005_bib0200","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1021\/jm801640k","article-title":"Development of novel aminoglycoside (NB54) with reduced toxicity and enhanced suppression of disease-causing premature stop mutations","volume":"52","author":"Nudelman","year":"2009","journal-title":"J Med Chem"},{"key":"10.1016\/j.anl.2016.10.005_bib0205","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/00125817-200209000-00004","article-title":"Genetic susceptibility to aminoglycoside ototoxicity: how many are at risk?","volume":"4","author":"Tang","year":"2002","journal-title":"Genet Med"},{"key":"10.1016\/j.anl.2016.10.005_bib0210","series-title":"Companion handbook to the WHO guidelines for the programmatic management of drug-resistant tuberculosis","first-page":"100","author":"World Health Organization","year":"2014"},{"issue":"Suppl. 12","key":"10.1016\/j.anl.2016.10.005_bib0215","first-page":"11","article-title":"Guidelines for the audiologic management of individuals receiving cochleotoxic drug therapy","volume":"36","author":"ASHA","year":"1994","journal-title":"Asha"},{"key":"10.1016\/j.anl.2016.10.005_bib0220","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1016\/j.rmed.2006.01.014","article-title":"Side effects due to primary antituberculosis drugs during the initial phase of therapy in 1149 hospitalized patients for tuberculosis","volume":"100","author":"G\u00fclbay","year":"2006","journal-title":"Respir Med"},{"key":"10.1016\/j.anl.2016.10.005_bib0225","first-page":"1","article-title":"Audiologic monitoring of multi-drug resistant tuberculosis patients on aminoglycoside treatment with long term follow-up","volume":"12","author":"Duggal","year":"2007","journal-title":"BMC Ear Nose Throat Disord"},{"key":"10.1016\/j.anl.2016.10.005_bib0230","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.tox.2008.04.015","article-title":"Aminoglycoside induced ototoxicity","volume":"249","author":"Guthrie","year":"2008","journal-title":"Toxicology"},{"key":"10.1016\/j.anl.2016.10.005_bib0235","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1345\/aph.1L001","article-title":"Aminoglycoside-induced vestibular injury: maintaining a sense of balance","volume":"42","author":"Ariano","year":"2008","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.anl.2016.10.005_bib0240","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/00129492-200407000-00025","article-title":"Permanent gentamicin vestibulotoxicity","volume":"25","author":"Black","year":"2004","journal-title":"Otol Neurotol"},{"key":"10.1016\/j.anl.2016.10.005_bib0245","first-page":"256","article-title":"Ototoxicity in Nigeria: why it persists","volume":"93","author":"Kokong","year":"2014","journal-title":"Ear Nose Throat J"},{"key":"10.1016\/j.anl.2016.10.005_bib0250","doi-asserted-by":"crossref","first-page":"244","DOI":"10.4103\/0300-1652.119648","article-title":"Assessment of the risk factors for hearing loss in adult Nigerian population","volume":"54","author":"Sogebi","year":"2013","journal-title":"Niger Med J"},{"key":"10.1016\/j.anl.2016.10.005_bib0255","doi-asserted-by":"crossref","first-page":"12","DOI":"10.5152\/iao.2015.650","article-title":"N-acetylcysteine prevents gentamicin ototoxicity in a rat model","volume":"11","author":"Somda\u015f","year":"2015","journal-title":"J Int Adv Otol"},{"key":"10.1016\/j.anl.2016.10.005_bib0260","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/ng0793-289","article-title":"Mitochondrial ribosomal RNA mutation associated with both antibiotic-induced and non-syndromic deafness","volume":"4","author":"Prezant","year":"1993","journal-title":"Nat Genet"},{"issue":"Pt 2","key":"10.1016\/j.anl.2016.10.005_bib0265","doi-asserted-by":"crossref","first-page":"363","DOI":"10.7196\/SAMJ.4964","article-title":"Aminoglycoside-induced hearing loss in HIV-positive and HIV-negative multidrug-resistant tuberculosis patients","volume":"102","author":"Harris","year":"2012","journal-title":"S Afr Med J"},{"key":"10.1016\/j.anl.2016.10.005_bib0270","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0378-5955(01)00303-3","article-title":"Aminoglycoside ototoxicity in adult CBA, C57BL and BALB mice and the Sprague-Dawley rat","volume":"158","author":"Wu","year":"2001","journal-title":"Hear Res"},{"key":"10.1016\/j.anl.2016.10.005_bib0275","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.jcf.2014.07.009","article-title":"High-frequency audiometry reveals high prevalence of aminoglycoside ototoxicity in children with cystic fibrosis","volume":"14","author":"Al-Malky","year":"2015","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.anl.2016.10.005_bib0280","doi-asserted-by":"crossref","first-page":"701","DOI":"10.5694\/mja11.10850","article-title":"Gentamicin ototoxicity: a 23-year selected case series of 103 patients","volume":"196","author":"Ahmed","year":"2012","journal-title":"Med J Aust"},{"key":"10.1016\/j.anl.2016.10.005_bib0285","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1093\/jac\/dkr221","article-title":"Multidrug-resistant tuberculosis (MDR-TB) treatment in the UK: a study of injectable use and toxicity in practice","volume":"66","author":"Sturdy","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.anl.2016.10.005_bib0290","doi-asserted-by":"crossref","first-page":"1","DOI":"10.9734\/BJMMR\/2016\/24421","article-title":"Vestibulo-otologic events in drug resistant Tuberculosis patients on medications","volume":"14","author":"Sogebi","year":"2016","journal-title":"Br J Med Med Res"},{"key":"10.1016\/j.anl.2016.10.005_bib0295","doi-asserted-by":"crossref","first-page":"298ra118","DOI":"10.1126\/scitranslmed.aac5546","article-title":"Endotoxemia-mediated inflammation potentiates aminoglycoside-induced ototoxicity","volume":"7","author":"Koo","year":"2015","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.anl.2016.10.005_bib0300","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0378-5955(90)90031-J","article-title":"Ultrastructural localization of gentamicin in the cochlea","volume":"50","author":"De Groot","year":"1990","journal-title":"Hear Res"},{"key":"10.1016\/j.anl.2016.10.005_bib0305","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s10162-002-2036-8","article-title":"Distribution of gentamicin in the guinea pig inner ear after local or systemic application","volume":"4","author":"Imamura","year":"2003","journal-title":"J Assoc Res Otolaryngol"},{"key":"10.1016\/j.anl.2016.10.005_bib0310","series-title":"Position statement and clinical practice guidelines: ototoxicity monitoring","author":"American Academy of Audiology","year":"2009"},{"key":"10.1016\/j.anl.2016.10.005_bib0315","doi-asserted-by":"crossref","first-page":"401","DOI":"10.5414\/CP201833","article-title":"Lack of a relationship between the serum concentration of aminoglycosides and ototoxicity in neonates","volume":"51","author":"Setiabudy","year":"2013","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.anl.2016.10.005_bib0320","doi-asserted-by":"crossref","first-page":"6337","DOI":"10.1128\/AAC.01050-15","article-title":"Amikacin concentrations predictive of ototoxicity in multidrug-resistant tuberculosis patients","volume":"59","author":"Modongo","year":"2015","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Auris Nasus Larynx"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0385814616304746?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0385814616304746?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T19:32:35Z","timestamp":1759951955000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0385814616304746"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S0385814616304746"],"URL":"https:\/\/doi.org\/10.1016\/j.anl.2016.10.005","relation":{},"ISSN":["0385-8146"],"issn-type":[{"value":"0385-8146","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical predictors of aminoglycoside-induced ototoxicity in drug-resistant Tuberculosis patients on intensive therapy","name":"articletitle","label":"Article Title"},{"value":"Auris Nasus Larynx","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anl.2016.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}